glucagon like peptide 1 glp 1 receptor agonist Glucagon-like peptide-1 (GLP-1) agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic Glucagon-like peptide 1(GLP-1) receptor agonists

Currently used antidepressant drugs, which mostly target brain monoaminergic neurotransmission, have limited clinical efficacy

Depression is a highly prevalent mood disorder and one of the major health concerns in modern society

Remember: Constipation is a common side effect of GLP-1 agonists, but it's manageable with the right strategies

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

DNF-10 yeast peptides have been shown to help reduce cravings and quiet the food talk

95% CI 0.35, 3.14)